Drug: EFAVIRENZ Injury: Virologic failure Quarter: 2016Q3
Total Records: 10 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125305061 | EFAVIRENZ | Virologic failure | GLAXOSMITHKLINE | 61.00 YR | F | 0 | 20160706 | ZA |
125310241 | EFAVIRENZ | Virologic failure | VIIV | 61.00 YR | F | 0 | 20160706 | ZA |
125448411 | EFAVIRENZ | Virologic failure | VIIV | 44.00 YR | M | 0 | 20160711 | ZA |
125448421 | EFAVIRENZ | Virologic failure | VIIV | 23.00 YR | F | 0 | 20160711 | ZA |
125448431 | EFAVIRENZ | Virologic failure | VIIV | 23.00 YR | M | 0 | 20160711 | ZA |
125467001 | EFAVIRENZ | Virologic failure | GLAXOSMITHKLINE | 23.00 YR | M | 0 | 20160711 | ZA |
125467011 | EFAVIRENZ | Virologic failure | GLAXOSMITHKLINE | 23.00 YR | F | 0 | 20160711 | ZA |
125467021 | EFAVIRENZ | Virologic failure | GLAXOSMITHKLINE | 44.00 YR | M | 0 | 20160711 | ZA |
126882431 | Efavirenz | Virologic failure | CIPLA | 0.00 | 0 | 20160826 | IT | |
126924641 | Efavirenz | Virologic failure | CIPLA | 0.00 | 0 | 20160829 | CA |
Total Records: 10 Number of Pages: 1